Akinaga S - Search Results

1

Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.

Suzuki M, Ishida H, Shiotsu Y, Nakata T, Akinaga S, Takashima S, Utsumi T, Saeki T, Harada N. Suzuki M, et al. Among authors: akinaga s. J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):195-201. doi: 10.1016/j.jsbmb.2008.12.008. Epub 2008 Dec 30. J Steroid Biochem Mol Biol. 2009. PMID: 19159687

2

Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma.

Suzuki T, Miki Y, Nakata T, Shiotsu Y, Akinaga S, Inoue K, Ishida T, Kimura M, Moriya T, Sasano H. Suzuki T, et al. Among authors: akinaga s. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):449-54. doi: 10.1016/s0960-0760(03)00356-x. J Steroid Biochem Mol Biol. 2003. PMID: 14623543

3

Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.

Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T. Nakata T, et al. Among authors: akinaga s. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):455-60. doi: 10.1016/s0960-0760(03)00357-1. J Steroid Biochem Mol Biol. 2003. PMID: 14623544

4

A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.

Ishida H, Nakata T, Suzuki M, Shiotsu Y, Tanaka H, Sato N, Terasaki Y, Takebayashi M, Anazawa H, Murakata C, Li PK, Kuwabara T, Akinaga S. Ishida H, et al. Among authors: akinaga s. Breast Cancer Res Treat. 2007 Dec;106(2):215-27. doi: 10.1007/s10549-007-9495-x. Epub 2007 Feb 1. Breast Cancer Res Treat. 2007. PMID: 17268815

5

Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.

Ishida H, Nakata T, Sato N, Li PK, Kuwabara T, Akinaga S. Ishida H, et al. Among authors: akinaga s. Breast Cancer Res Treat. 2007 Aug;104(2):211-9. doi: 10.1007/s10549-006-9404-8. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061037

6

Development of radicicol analogues.

Soga S, Shiotsu Y, Akinaga S, Sharma SV. Soga S, et al. Among authors: akinaga s. Curr Cancer Drug Targets. 2003 Oct;3(5):359-69. doi: 10.2174/1568009033481859. Curr Cancer Drug Targets. 2003. PMID: 14529387 Review.

7

Heat shock protein 90-antagonist destabilizes Bcr-Abl/HSP90 chaperone complex.

Shiotsu Y, Soga S, Akinaga S. Shiotsu Y, et al. Among authors: akinaga s. Leuk Lymphoma. 2002 May;43(5):961-8. doi: 10.1080/10428190290021371. Leuk Lymphoma. 2002. PMID: 12148906 Review. No abstract available.

8

Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development.

Soga S, Akinaga S, Shiotsu Y. Soga S, et al. Among authors: akinaga s. Curr Pharm Des. 2013;19(3):366-76. doi: 10.2174/138161213804143617. Curr Pharm Des. 2013. PMID: 22920907 Review.

9

Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H. Suzuki T, et al. Among authors: akinaga s. Cancer Res. 2003 Jun 1;63(11):2762-70. Cancer Res. 2003. PMID: 12782580

10

Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length.

Nakai R, Ishida H, Asai A, Ogawa H, Yamamoto Y, Kawasaki H, Akinaga S, Mizukami T, Yamashita Y. Nakai R, et al. Among authors: akinaga s. Chem Biol. 2006 Feb;13(2):183-90. doi: 10.1016/j.chembiol.2005.11.010. Chem Biol. 2006. PMID: 16492566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters